Daveen chopra edwards lifesciences
WebJul 15, 2024 · IRVINE, Calif., July 15, 2024 - Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and … WebJan 31, 2024 · AUSTIN, Texas, Jan. 31, 2024 - Edwards Lifesciences (NYSE: EW) today announced new data from the COMMENCE clinical trial that demonstrate Edwards' bioprosthetic surgical aortic valve with the company's novel RESILIA tissue platform show favorable safety and hemodynamic performance through a median of five years follow …
Daveen chopra edwards lifesciences
Did you know?
WebApr 9, 2024 · In other Edwards Lifesciences news, VP Daveen Chopra sold 4,000 shares of the business's stock in a transaction on Wednesday, February 15th. The shares were sold at an average price of $76.01, for a total transaction of $304,040.00. Following the completion of the sale, the vice president now owns 18,911 shares in the company, … WebMar 31, 2024 · Edwards Lifesciences (NYSE: EW) today announced it received approval from the U.S. Food and Drug Administration (FDA) for the MITRIS RESILIA valve, a …
WebApr 13, 2024 · In other Edwards Lifesciences news, VP Daveen Chopra sold 4,000 shares of the stock in a transaction dated Tuesday, January 17th. The shares were sold at an average price of $78.00, for a total value of $312,000.00. Following the transaction, the vice president now directly owns 18,911 shares of the company's stock, valued at … WebApr 14, 2024 · Edwards Lifesciences Co. has a 52-week low of $67.13 and a 52-week high of $131.10. The stock has a 50-day simple moving average of $79.72 and a 200-day …
WebApr 9, 2024 · Insider Buying and Selling at Edwards Lifesciences. In other news, VP Daveen Chopra sold 4,000 shares of the stock in a transaction that occurred on … WebFeb 1, 2024 · Edwards Lifesciences announced that its RESILIA tissue aortic valve has shown favourable safety and efficacy at five years in the COMMENCE clinical trial. ... Edwards’ surgical structural heart corporate vice president Daveen Chopra said: “Beyond the COMMENCE study, Edwards continues to invest in research to examine different …
WebApr 11, 2024 · In other news, VP Daveen Chopra sold 4,000 shares of Edwards Lifesciences stock in a transaction dated Wednesday, February 15th. The stock was sold at an average price of $76.01, for a total value ...
WebApr 3, 2024 · On average, sell-side analysts forecast that Edwards Lifesciences Co. will post 2.52 EPS for the current fiscal year. Insider Activity. In other news, VP Daveen Chopra this link the SEC website ... raychem at 180WebApr 13, 2024 · In other Edwards Lifesciences news, VP Daveen Chopra sold 4,000 shares of the stock in a transaction dated Tuesday, January 17th. The shares were sold … raychem ate 180WebApr 14, 2024 · Also, VP Daveen Chopra sold 4,000 shares of Edwards Lifesciences stock in a transaction on Tuesday, January 17th. The shares were sold at an average price of … simple shelving plansWebThe colleagues of Daveen Chopra. At Edwards Lifesciences, Daveen Chopra has 30 colleagues including Michael Mussallem (CEO (-> May 11 2024)), Kieran Gallahue … simple shepherd costumeWebMar 15, 2024 · Mr. Chopra EW stock SEC Form 4 insiders trading. Daveen has made over 10 trades of the Edwards Lifesciences Corp stock since 2024, according to the Form 4 … simple shelving unitWebApr 10, 2024 · Also, VP Daveen Chopra sold 4,000 shares of Edwards Lifesciences stock in a transaction on Tuesday, January 17th. The stock was sold at an average price of $78.00, for a total value of $312,000.00. raychem at-180WebDaveen Chopra is VP/Gen Mgr:TMTT Business at Edwards Lifesciences Corp. See Daveen Chopra's compensation, career history, education, & memberships. simple shepherd\\u0027s pie recipe uk